Prof. Adam E. Snook
Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA
About this speaker
Adam E. Snook, PhD
Associate Professor, Departments of Pharmacology, Physiology, & Cancer Biology and Microbiology & Immunology
Associate Director, Clinical & Translational Research, JeffMD Scholarly Inquiry Program
Assistant Program Leader, Immune Cell Regulation and Targeting (IRT) Program, Sidney Kimmel Cancer Center
Adam Snook, PhD is an Associate Professor in the Department of Pharmacology, Physiology, & Cancer Biology, with a secondary appointment in the Department of Microbiology & Immunology, at Thomas Jefferson University. He is an Assistant Program Leader of the Immune Cell Regulation and Targeting (IRT) Program of the Sidney Kimmel Cancer Center. He is also Associate Director of the Clinical & Translational Research track of the JeffMD Scholarly Inquiry Program of the Sidney Kimmel Medical College.
Dr. Snook received a B.S. in Pharmacology and Toxicology (2001) from the University of the Sciences and a Ph.D. in Immunology and Microbial Pathogenesis (2008) from Thomas Jefferson University. He was a founding member and served as the Director of Antibody Development for 5 years at Invisible Sentinel, Inc. a leading molecular solutions company specializing in food safety and a current subsidiary of bioMérieux.
He joined the Jefferson faculty in 2013, where he is studying the interaction between cancer and the immune system to develop new options to prevent or treat gastrointestinal cancers. His work has led to 7 investigator-initiated clinical trials examining colorectal cancer chemoprevention, cancer vaccines, and CAR-T cell therapies.
